All Stories

  1. Analytical performance of the VITA™ point-of-care CD4 enumeration assay
  2. Analytical performance of the VITA™ point-of-care CD4 enumeration assay
  3. An extension of the Spiegelhalter-Knill-Jones method for continuous covariates in clinical decision making
  4. Guidelines for Integrating actionable A-SMART Learning Outcomes into the Backward Design Process
  5. COVID-19 outbreaks in endangered Indigenous groups from the Amazonia during the first wave of the COVID-19 pandemic in Ecuador: a retrospective cross-sectional study
  6. Ethnic, geographical and altitude considerations and maternal mortality associated with HELLP syndrome in Ecuador: a population-based cohort study
  7. clinical prediction score
  8. Development of antepartum risk prediction model for postpartum hemorrhage in Lagos, Nigeria: A prospective cohort study (Predict‐PPH study)
  9. Shaping the future of global access to safe, effective, appropriate and quality health products
  10. Piloting a new method to estimate action thresholds in medicine through intuitive weighing
  11. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry
  12. Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
  13. High SARS-CoV-2 infection rates and viral loads in community-dwelling individuals from rural indigenous and mestizo communities from the Andes during the first wave of the COVID-19 pandemic in Ecuador
  14. Ethnodemographic characterization of stroke incidence and burden of disease in hospital discharge records in Ecuador
  15. The therapeutic threshold in clinical decision-making for TB
  16. Sustained COVID-19 community transmission and potential super spreading events at neglected afro-ecuadorian communities assessed by massive RT-qPCR and serological testing of community dwelling population
  17. ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19
  18. Carga de enfermedad por cáncer de cuello uterino en Ecuador, periodo 2015-2020
  19. SARS-CoV-2 Viral Load Analysis at Low and High Altitude: A Case Study from Ecuador
  20. Female homicides and femicides in Ecuador: a nationwide ecological analysis from 2001 to 2017
  21. HIV Rapid Testing in the General Population and the Usefulness of PrEP in Ecuador: A Cost–Utility Analysis
  22. High SARS-CoV-2 Infection Rates Among Special Forces Police Units During the Early Phase of the COVID-19 Pandemic in Ecuador
  23. Diagnostic Performance of Seven Commercial COVID-19 Serology Tests Available in South America
  24. Clinical characteristics, risk factors and outcomes in patients with severe COVID-19 registered in the International Severe Acute Respiratory and Emerging Infection Consortium WHO clinical characterisation protocol: a prospective, multinational, multic...
  25. Crucial contribution of the universities to SARS-CoV-2 surveillance in Ecuador: Lessons for developing countries
  26. Carga de enfermedad por insuficiencia cardiaca en Ecuador durante el periodo 2014-2018
  27. Ten months of temporal variation in the clinical journey of hospitalised patients with COVID-19: An observational cohort
  28. Stroke-Related Mortality at Different Altitudes: A 17-Year Nationwide Population-Based Analysis From Ecuador
  29. COVID-19 outbreaks among isolated Amazonian indigenous people, Ecuador
  30. COVID-19 outbreaks at shelters for women who are victims of gender-based violence from Ecuador
  31. COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study
  32. High prevalence of SARS-CoV-2 infection among food delivery riders. A case study from Quito, Ecuador
  33. Massive SARS-CoV-2 RT-PCR Testing on Rural Communities in Manabi Province (Ecuador) Reveals Severe COVID-19 Outbreaks
  34. Testing for SARS-CoV-2 at the core of voluntary collective isolation: Lessons from the indigenous populations living in the Amazon region in Ecuador
  35. A population-based study of preeclampsia and eclampsia in Ecuador: ethnic, geographical and altitudes differences
  36. Epidemiological, socio-demographic and clinical features of the early phase of the COVID-19 epidemic in Ecuador
  37. Assessing the burden and spatial distribution of Taenia solium human neurocysticercosis in Ecuador (2013–2017)
  38. The burden of cutaneous and mucocutaneous leishmaniasis in Ecuador (2014-2018), a national registry-based study
  39. Thyroid Cancer in Ecuador, a 16 years population-based analysis (2001–2016)
  40. The burden of acute respiratory infections in Ecuador 2011-2015
  41. Rational use of Xpert testing in patients with presumptive TB: clinicians should be encouraged to use the test-treat threshold
  42. The disease burden of suicide in Ecuador, a 15 years’ geodemographic cross-sectional study (2001–2015)
  43. Costo De La Inmunización De Rutina En Menores De Un Año En El Año 2016 En El Ecuador
  44. Costo-Efectividad De La Deteccion De Adn De Virus De Papiloma Humano De Alto Riesgo Para Tamizaje De Cancer De Cuello Uterino En Ecuador
  45. Analysis of the cost–effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador
  46. Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador
  47. Analysis of Health and Drug Access Associated with the Purchasing Power of the Ecuadorian Population
  48. Bias control in shared decision making: still too many loose ends
  49. Can we improve adherence to guidelines for the treatment of lower urinary tract infection? A simple, multifaceted intervention in out-of-hours services
  50. Comment on ‘A qualitative approach to Bayes’ theorem' by Medow and Lucey